• Login
    View Item 
    •   Research Bank Home
    • Unitec Institute of Technology
    • Study Areas
    • Health Sciences
    • Health Sciences Conference Papers
    • View Item
    •   Research Bank Home
    • Unitec Institute of Technology
    • Study Areas
    • Health Sciences
    • Health Sciences Conference Papers
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Developed and validated script for 18F – PSMA -1007 Synthesis in IBA – Synthera version-01

    Sharma, S.; Kar, B.N.; Soni, P.S.; Kumar, P.; Gowda, K.B.; M, Kavi Arasu; Vyas, Madhusudan

    Thumbnail
    Share
    View fulltext online
    Sharma, S. (2022).pdf (327.9Kb)
    Date
    2022-06
    Citation:
    Sharma, S.; Kar, B.N.; Soni, P.S.; Kumar, P.; Gowda, K.B.; M, Kavi Arasu; Vyas, M. (2022). Developed and validated script for 18F – PSMA -1007 Synthesis in IBA – Synthera version-01. SNMMI-2022 (pp. 1535-5678).
    Permanent link to Research Bank record:
    https://hdl.handle.net/10652/5785
    Abstract
    Prostate cancer is the most frequent cancer among males around the world. According to the American Cancer Society's website, one out of every nine males is likely to be diagnosed with prostate cancer [1]. It is the world's second greatest cause of death among males. PSA, or prostate-specific antigen, is a popular biomarker for prostate cancer. For early disease detection, standard imaging technologies such as CT and MRI have not proved sufficient information. PET imaging in conjunction with CT/MRI is a useful tool for detecting prostate cancer [2]. PSMA (prostate-specific membrane antigen) tagged with radioisotopes is a promising agent for both early detection and therapy of prostate cancer. In prostate cancer cells, PSMA is overexpressed. As a service provider, we decided to create and supply the 18F-PSMA 1007 in response to the clinical need for PSMA in nuclear medicine departments. We've been commercially generating 18F-FDG and 18F NaF since 2009, and we thought 18F-PSMA was a tracer with clinical potential as well as economic potential and added value to the company. Despite the fact that we had already purchased a synthesiser (Trasis AllInOne) capable of producing 18F-PSMA-1007, installation and commissioning were nowhere to be found. As a result, we used Synthera v1 to make 18F-PSMA-1007 (Synthera v1; already retired by IBA, the manufacturer). Regent kits to make 18F-PSMA-1007 with more recent versions of Synthera (Synthera v2 and Synthera Plus) were available, and the product may be used in our experiments, but there was no approved synthesis script / sequence for Synthera v1. As a result, the first task was to write the /sequence script.
    Keywords:
    cancer patients, prostate cancer, prostate-specific membrane antigen (PSMA), radionuclide therapy, medical imaging
    ANZSRC Field of Research:
    3211 Oncology and carcinogenesis, 320215 Nuclear medicine
    Copyright Holder:
    Author

    Copyright Notice:
    All rights reserved
    Rights:
    This digital work is protected by copyright. It may be consulted by you, provided you comply with the provisions of the Act and the following conditions of use. These documents or images may be used for research or private study purposes. Whether they can be used for any other purpose depends upon the Copyright Notice above. You will recognise the author's and publishers rights and give due acknowledgement where appropriate.
    Metadata
    Show detailed record
    This item appears in
    • Health Sciences Conference Papers [18]

    Te Pūkenga

    Research Bank is part of Te Pūkenga - New Zealand Institute of Skills and Technology

    • About Te Pūkenga
    • Privacy Notice

    Copyright ©2022 Te Pūkenga

    Usage

    Downloads, last 12 months
    29
     
     

    Usage Statistics

    For this itemFor the Research Bank

    Share

    About

    About Research BankContact us

    Help for authors  

    How to add research

    Register for updates  

    LoginRegister

    Browse Research Bank  

    EverywhereInstitutionsStudy AreaAuthorDateSubjectTitleType of researchSupervisorCollaboratorThis CollectionStudy AreaAuthorDateSubjectTitleType of researchSupervisorCollaborator

    Te Pūkenga

    Research Bank is part of Te Pūkenga - New Zealand Institute of Skills and Technology

    • About Te Pūkenga
    • Privacy Notice

    Copyright ©2022 Te Pūkenga